Key result
Intravenous administration of therapeutic doses of esmolol hydrochloride was associated with generalized convulsions in a single patient.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
Therapeutic doses of intravenous esmolol can rarely induce generalized convulsions, an adverse event previously associated only with beta-blocker overdose.
Beta-receptor blocking agents are commonly used to treat patients with heart disease, and generalized seizures due to therapy with these agents are rare. All reported cases of seizures due to beta blocking agents have occurred only in those subjects who ingested large doses of the drugs. We observed generalized convulsions in a patient who was receiving therapeutic doses of an ultrashort-acting beta-blocking agent (esmolol hydrochloride) intravenously. A literature survey and possible mechanisms by which these agents induce seizures are presented.
No takes yet. Share an insight, caveat, or question.
Das et al. (1988) conducted a case report in Heart disease (n=1). Esmolol hydrochloride was evaluated on Generalized convulsions. Intravenous administration of therapeutic doses of esmolol hydrochloride was associated with generalized convulsions in a single patient.
Synapse has enriched 10 related papers. Consider them for comparative context: